Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients
Background. Clopidogrel inhibits the ADP receptor P2Y12 to keep down the platelet aggregation. The goal of our study is to investigate the contribution of P2Y12 promoter DNA methylation to the risk of clopidogrel resistance (CR). Methods. The platelet functions were measured by the VerifyNow P2Y12 a...
Main Authors: | Jia Su, Xiaojing Li, Qinglin Yu, Yahui Liu, Yaqing Wang, Haojun Song, Hanbin Cui, Weiping Du, Xiaohong Fei, Junsong Liu, Shaoyi Lin, Jian Wang, Wenyuan Zheng, Jinyan Zhong, Lulu Zhang, Maoqing Tong, Jin Xu, Xiaomin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/450814 |
Similar Items
-
The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
by: Jia Su, et al.
Published: (2017-01-01) -
Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans
by: Jin Yang, et al.
Published: (2021-01-01) -
The expression profile of platelet‐derived miRNA in coronary artery disease patients with clopidogrel resistance
by: Shaoyi Lin, et al.
Published: (2021-04-01) -
A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
by: Zhaojian Zhang, et al.
Published: (2019-01-01) -
Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2–Smad1/5/8 signaling pathway
by: Shuangshuang Wang, et al.
Published: (2018-06-01)